Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1973 Aug;52(8):1893-907.
doi: 10.1172/JCI107373.

Canine systemic lupus erythematosus. Transmission of serologic abnormalities by cell-free filtrates

Canine systemic lupus erythematosus. Transmission of serologic abnormalities by cell-free filtrates

R M Lewis et al. J Clin Invest. 1973 Aug.

Abstract

The presence of viruses was sought in a colony of dogs bred from parents with systemic lupus crythematosus (SLE). Cell-free filtrates prepared from the spleens of these animals were injected into newborn dogs, mice, and rats. The canine recipients developed antinuclear antibody (ANA) and positive lupus erythematosus (LE) cell tests: ANA and, in some cases, antinative DNA antibodies were produced by the murine recipients: no abnormalities were detected in the rats. Serial passage of spleen cells or cell-free filtrates of spleen tissue in syngeneic mice reduced the time required for appearance of ANA from 9 to 4 mo. Some murine recipients of the canine filtrate developed malignant lymphomas. Murine leukemia viruses were identified in these tumors by electron microscopic, virologic, and serologic technics. These neoplasms, but not other tumors known to contain murine leukemia viruses, were associated with the production of ANA. Puppies inoculated with the canine filtrate-induced mouse lymphoma developed ANA and positive LE cell tests within 4 mo. THE RESULTS WERE INTERPRETED TO INDICATE THE PRESENCE IN CANINE SLE OF A VIRUS CAPABLE OF: (a) inducing the serologic abnormalities of SLE in normal dogs and mice: (b) activating latent murine leukemia viruses: and (c) spreading by both horizonal and vertical routes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Med. 1968;19:269-82 - PubMed
    1. Blood. 1965 Feb;25:143-60 - PubMed
    1. Proc Natl Acad Sci U S A. 1969 Jul;63(3):753-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1969 Jul;63(3):820-7 - PubMed
    1. Science. 1970 May 22;168(3934):982-4 - PubMed

MeSH terms